GLP-1 Nutrition, Eye Health Formulations, and Japan FFC Market Evolve
The supplement industry is rapidly adapting to GLP-1 drug co-market opportunities, children's specific nutritional needs, and targeted eye health formulations. Japan's FFC market, despite stricter regulation, posted 4% growth, indicating sustained consumer demand.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
The market for 'companion' nutritional products supporting GLP-1 drug users is intensifying, attracting significant investment from major food and pharmaceutical players. Nestlé's aggressive strategy, which includes utilising AI for product development and consumer insights, signals a strategic pivot towards a broader nutritional category, moving beyond traditional supplement offerings. This follows the partnership between Novonesis and Novo Nordisk to investigate microbiome-targeted supplements for enhanced GLP-1 drug efficacy, highlighting a trend towards science-backed, integrated health solutions.
Simultaneously, the children's supplement sector is maturing beyond general multivitamins into targeted health solutions. Brands are responding to parental demand for specific benefits like immune support with innovative formats, demonstrating robust growth in tinctures (+81.7%), lozenges (+44.7%), and sprays (+31.6%). This diversification reflects a drive towards improved palatability and efficacy for younger demographics.
Eye health supplement innovation is also expanding beyond lutein and zeaxanthin, driven by increased screen exposure and blue light concerns. New formulations combine established carotenoids with omega-3s, B vitamins, hyaluronic acid, and other antioxidants. Japanese firm YURU Co Ltd's 'LUTE VITA' launch, featuring liposomal lutein, astaxanthin, and coenzyme Q10, exemplifies this trend towards multi-ingredient, advanced delivery systems. Furthermore, a discernible link between GLP-1 drug usage and hair loss is driving demand for hair growth supplements, creating a new niche within the beauty-from-within market, substantiated by emerging pharmacovigilance data.
What this means for Japan
Japanese manufacturers and brand owners face a dual challenge and opportunity. While the Foods with Function Claims (FFC) market grew by 4% in FY2025, new product notifications decreased by 26% year-on-year to 1,176, attributed to stricter Consumer Affairs Agency oversight post-2024 red yeast rice crisis. This environment mandates rigorous scientific substantiation and compliance, increasing pre-market costs but potentially reducing competitive saturation. Brands can leverage the sustained market growth by focusing on high-quality, scientifically sound products with clear FFC messaging. Procurement teams must anticipate longer lead times and higher R&D investment for new FFC formulations, with a focus on ingredients that align with evolving consumer needs such as eye health and metabolic support.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.